Low Testosterone Symptoms in Women: What to Do Next

Low testosterone symptoms in women can include persistent fatigue, low libido, and a flat mood, but these are common and non-specific. The major medical guidelines, from the Endocrine Society to the British Menopause Society, disagree on whether this even constitutes a diagnosable syndrome. The Endocrine Society and Province of British Columbia guidelines advise against routine testing for low libido alone, while the British Menopause Society suggests testing could be considered for specific symptoms. The primary evidence-based medical treatment is a short-term trial of testosterone for postmenopausal women with a formal diagnosis of Hypoactive Sexual Desire Disorder (HSDD), as per the Endocrine Society. The British Menopause Society, citing NICE, states it can also be considered for menopausal women with low sexual desire if HRT alone is not effective.

That disagreement between experts is the whole story. One set of guidelines says testing is useless for low libido; another suggests a specific blood index can guide treatment. This leaves women with real symptoms stuck between a doctor who follows the first rulebook and a clinic that markets the second.

What follows is a walk through the actual symptoms, the messy science of measurement, the specific guideline conflicts, and the narrow window where medical testosterone therapy is even on the table. We will also cover what to do first, before any hormone talk, because fatigue and low drive often point to simpler, fixable problems.

Key Takeaways

• The most common symptoms, fatigue, low libido, and mood changes, are vague and overlap heavily with low estrogen, thyroid issues, stress, and poor sleep.
• The Endocrine Society recommends against making a diagnosis of “androgen deficiency syndrome” in healthy women, citing a lack of a well-defined condition. In contrast, the British Menopause Society advises that testosterone indication could be extended to include menopausal women with low sexual desire and tiredness.
• The Province of British Columbia guidelines state that only tandem mass spectrometry (LC-MS/MS) is sufficiently sensitive to accurately measure the low total testosterone seen in normal females; standard direct immunoassays are often unreliable at these low levels.
• If treatment is pursued for postmenopausal HSDD, monitoring targets a Free Androgen Index (FAI) below 5% to avoid side effects like excess hair growth or acne.
• The first step is never a hormone test. Rule out deficiencies in iron, vitamin D, and thyroid function, and address sleep and stress, before considering androgen levels.

What Are the Symptoms of Low Testosterone in Women?

You will see the same list everywhere: low sex drive, persistent tiredness, muscle weakness, foggy thinking, and a dampened mood. The problem is that list is a dead ringer for low estrogen, an underactive thyroid, clinical depression, chronic stress, or just not sleeping enough, which complicates identifying low testosterone symptoms in women.

My rule from tracking my own health metrics is simple: a symptom shared by ten different conditions is a clue, not a diagnosis. It tells you where to look next, not what you have.

Common mistake: Attributing fatigue and low mood directly to hormones without a baseline check. Iron deficiency or a sluggish thyroid can produce identical symptoms, and correcting them is straightforward and cheap.

So what makes low testosterone suspect? It is the combination and persistence. It is not one bad week. It is a months-long drag where your get-up-and-go is gone, your interest in sex feels like a distant memory, and your muscles feel like they lost their spring, despite adequate sleep, decent nutrition, and no other major health changes.

The Overlap Problem: Is It Low T, Low Estrogen, or Your Thyroid?

This is where the conversation with a doctor about low testosterone symptoms in women often stalls. The symptoms are non-specific. A 2021 review in the Cleveland Clinic Journal of Medicine notes that clinicians should avoid diagnosing androgen deficiency in women precisely because the syndrome is not well defined. The clinical picture is too fuzzy.

To even have the discussion, other culprits must be ruled out. This means basic blood work: a complete blood count (for anemia), a thyroid panel (TSH, Free T4), and vitamin D levels. It is medical due diligence. Starting with a testosterone test when you are actually iron-deficient is a waste of time and money.

How Is Low Testosterone in Women Diagnosed?

This is the hardest part. Diagnosing low testosterone in women is controversial, technically difficult, and not routinely recommended for investigating low libido alone.

The Province of British Columbia guidelines state plainly: “Testosterone testing in women for the investigation of low libido is not useful.” The reason is that sexual desire is complex, tied to relationship quality, mental health, medications, and other hormones. A single hormone level rarely explains it.

Tandem mass spectrometry (LC-MS/MS) is the only method sufficiently sensitive to accurately measure the low total testosterone seen in normal females. Standard direct immunoassays often fail at this low range, giving unreliable numbers.

If testing proceeds, timing matters. Testosterone follows a diurnal rhythm, highest in the morning. The MedlinePlus Medical Encyclopedia states the best time for a blood draw is between 7 a.m. And 10 a.m. For the investigation of male hypogonadism, the Province of British Columbia guidelines specify collection within 3 hours of waking. For women, the MedlinePlus Medical Encyclopedia states the best time is between 7 a.m. And 10 a.m., though specific guidelines may vary.

The Role of the Free Androgen Index (FAI)

Since most testosterone is bound to a protein (SHBG), the “free” fraction is what’s biologically active. Measuring it directly is tricky. Instead, labs calculate a Free Androgen Index (FAI) using total testosterone and SHBG.

Here is where guidelines diverge. The British Menopause Society (BMS) suggests that in a symptomatic woman with a Free Androgen Index (FAI) of <1%, a trial of testosterone supplementation could be considered. This directly conflicts with the “testing is not useful” stance. It is the core of the diagnostic disagreement.

Guideline Source	Position on Testing for Low Libido	Key Diagnostic Metric (if any)
Province of British Columbia	Not useful.	Not specified.
Endocrine Society	Recommends against routine measurement.	No established correlation.
British Menopause Society	Could be considered for specific symptoms.	Free Androgen Index (FAI) <1%.

If you get tested, you need to know which assay the lab uses. Ask for LC-MS/MS. A number from a poor assay is worse than no number, it gives false confidence.

What Do the Major Medical Guidelines Say?

This is where the rubber meets the road. You cannot understand treatment options without knowing the rulebooks doctors follow. The two most influential are at odds.

The Endocrine Society’s Stance (Conservative)

Their clinical practice guideline is clear. They recommend against making a diagnosis of androgen deficiency syndrome in healthy women. The Endocrine Society recommends against the generalized use of testosterone by women for sexual dysfunction (except for HSDD in postmenopausal women), while the British Menopause Society, citing NICE, states testosterone can be considered for menopausal women with low sexual desire if HRT alone is not effective. Their view is that the evidence for a broader syndrome is thin and the risks of treatment are not fully known.

The British Menopause Society’s View (More Pragmatic)

Citing NICE guidelines, the British Journal of General Practice states testosterone supplementation can be considered for menopausal women with low sexual desire if hormone replacement therapy (HRT) alone is not effective. Separately, the British Menopause Society (BMS) 2016 recommendations advise that testosterone indication could be extended to include menopausal women with low sexual desire and tiredness. They extend this to include women with low desire and tiredness. BMS guidance suggests that in a symptomatic woman with a Free Androgen Index (FAI) of <1%, a trial of testosterone supplementation could be considered. For monitoring, current BMS guidance suggests the FAI should be maintained at <5%.

Where this goes sideways: Starting treatment based on symptoms alone, without excluding other causes like medication side effects, relationship stress, or untreated depression. The Cleveland Clinic Journal review mandates a thorough medical and psychosocial assessment first.

The takeaway? Your doctor’s approach will depend on which guideline they prioritize. A reproductive endocrinologist might lean Endocrine Society. A menopause specialist might follow BMS. This is why getting a second opinion is sometimes necessary.

When Is Testosterone Therapy Actually Prescribed?

The Endocrine Society states the only evidence-based indication for testosterone therapy in women is for the treatment of HSDD in postmenopausal women. The British Menopause Society and NICE guidelines present a broader consideration for menopausal women with low sexual desire. HSDD is not just “I wish I wanted sex more.” It is a defined condition: absent sexual thoughts, no responsive desire, and resulting personal distress.

Even then, it is a last resort. The Endocrine Society suggests a 3- to 6-month trial of a dose of testosterone for postmenopausal women with properly diagnosed HSDD. If there is no meaningful improvement in desire and distress by six months, therapy should stop.

What Treatment Looks Like

No testosterone formulation is FDA-approved for women in the United States. This forces doctors to use products designed for men, which is risky. The Cleveland Clinic Journal of Medicine advises that women should be prescribed a tenth of the recommended male dose, or less, to avoid supraphysiologic dosing.

• Preferred Method: Transdermal gels or creams, applied to the inner thigh, abdomen, or buttock. Avoid the breast and arms.
• The Cleveland Clinic Journal of Medicine notes that oral testosterone undergoes first-pass metabolism and tends to be associated with more side effects; the most recent consensus statement discourages its use. It also states intramuscular and pellet therapies should be avoided.
• The One Approved Androgen: For genitourinary syndrome of menopause (vaginal dryness, pain), the only FDA-approved vaginal androgen is intravaginal DHEA 6.5 mg (prasterone).

Here is a critical monitoring table. If your doctor does not follow a protocol like this, ask why.

Monitoring Step	Timing	Purpose
Baseline Testosterone Level	Before starting	To gauge starting point and calculate dose.
Follow-up Level	3–6 weeks after initiation	To check for overuse and ensure levels are not too high.
Ongoing Monitoring	Every 6 months	To maintain levels in the target range (FAI <5%) and check for side effects.
Clinical Response Check	At 6 months	To decide whether to continue therapy. No response means stop.

The goal is to keep serum testosterone levels such that they approximate normal physiologic levels of a premenopausal woman to avoid side effects. The Cleveland Clinic Journal of Medicine states that when hormone levels on treatment approximate normal physiologic levels of a premenopausal woman, there is no significant increased risk of alopecia, clitoromegaly, or voice changes. Separately, the British Journal of General Practice notes that transdermal testosterone is not associated with an increase in blood pressure and has no adverse effects on lipid profile. The Cleveland Clinic Journal of Medicine reports that the risk of vaginal bleeding was increased in users of the 300-μg/day patch, though no increased risk of endometrial hypertrophy was observed over 12 months.

What Should You Do If You Have These Symptoms?

Talk to your doctor, but walk in prepared. The goal is to move from “I think my testosterone is low” to systematically ruling out the common causes of fatigue and low drive.

1. Track Your Symptoms. Keep a simple two-week log. Note energy levels (1-10), sleep hours, mood, stress, and any interest in sex. Patterns emerge. You might see that low days follow poor sleep or high stress, not a random hormone fluctuation.
2. Request Basic Blood Work. Before any hormone panel, ask for:
   • Complete Blood Count (CBC) (rules out anemia)
   • Thyroid-Stimulating Hormone (TSH) and Free T4 (rules out hypothyroidism)
   • Ferritin (iron stores)
   • Vitamin D (25-hydroxy) This is the foundational check. I wasted time guessing before testing. Now I test first.
3. Optimize the Basics. You cannot out-supplement a bad foundation. Address sleep hygiene, manage stress (yes, it lowers SHBG), ensure adequate protein intake, and consider a multivitamin to cover potential deficiencies in B12, magnesium, and zinc.
4. Discuss Hormone Testing Carefully. If basics are normal and symptoms persist, you can discuss testosterone testing. Frame it as part of a broader investigation. Specify that you want the test done with a tandem mass spectrometry (LC-MS/MS) assay, in the morning. Ask for total testosterone, SHBG, and the calculated Free Androgen Index.

This process is slow. It is frustrating. But it prevents the far greater frustration of treating the wrong problem for a year.

What are normal testosterone levels for women?

Defining a normal range for testosterone in women is complicated. The Endocrine Society recommends against routinely measuring testosterone in women for diagnosis. The Endocrine Society recommends against making a clinical diagnosis of androgen deficiency syndrome in healthy women, as it is not a well-defined condition. For investigations where measurement is considered, accurate testing is a challenge. Only a specific method called tandem mass spectrometry (LC-MS/MS) is considered sufficiently sensitive to measure the low levels typically found in women. If a test is performed, guidelines suggest the best time for a blood sample is in the morning, within a few hours of waking, due to natural daily variation. A single low result often needs confirmation with a second test.

Frequently Asked Questions

How does a female know if she has low testosterone?

She does not know, not for sure. The symptoms are too common. She can suspect it if she has persistent, unexplained fatigue, a vanished libido, and muscle weakness after ruling out far more common issues like iron deficiency, thyroid problems, and clinical depression. A blood test using a precise assay is the only way to measure it, but even a low number may not be the cause of her symptoms.

What is the best natural way to increase testosterone in women?

The evidence for “natural boosters” in women is sparse. The most reliable strategies are not about boosting testosterone directly but about supporting overall endocrine health: strength training to maintain muscle mass, ensuring adequate intake of zinc and magnesium (common deficiencies), managing chronic stress (which elevates cortisol and can disrupt hormone balance), and prioritizing sleep. There is no supplement with robust data for raising testosterone in otherwise healthy women.

What causes low testosterone in women?

The main cause is age. Testosterone levels naturally decline from a woman’s 20s onward. Other causes include surgical removal of the ovaries (oophorectomy), adrenal insufficiency, pituitary gland disorders, and certain medications like oral corticosteroids or some hormonal contraceptives. The Endocrine Society recommends against the routine treatment of women with low androgen levels due to hypopituitarism, adrenal insufficiency, bilateral oophorectomy, or other conditions.

Can young women have low testosterone?

Yes, but it is less common and often tied to an underlying condition. Young athletes with very low body fat, women with hypothalamic amenorrhea (loss of period due to stress/over-exercise), or those with pituitary issues can have low levels. In otherwise healthy young women, extreme fatigue and low libido are much more likely due to overtraining, nutrient deficiencies, or mental health factors than to a primary androgen deficiency.

Before You Go

Women’s testosterone treatment is an area of caution and contradiction. The symptoms are real for those experiencing them, but the medical response is rightly guarded. The strongest consensus from sources like the Endocrine Society clinical practice guideline is to look everywhere else first.

If you take one action, make it the two-week symptom and habit log. That cheap, boring journal will tell you more than any initial hormone panel. It turns vague feelings into observable data you can bring to a doctor.

And if the conversation does turn to hormones, remember the narrow path: precise testing, a specific diagnosis (HSDD), and closely monitored, short-term therapy. Outside of that path, the risks of unproven treatments far outweigh the potential benefits. Your energy and drive are worth investigating, just start with the fundamentals, not the fringe.